Agency Information Collection Activities: Submission for OMB Review; Comment Request
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The Centers for Medicare & Medicaid Services (CMS) is requesting public comments regarding its intention to collect information under the Paperwork Reduction Act of 1995. This notice outlines the process for public input on proposed information collections, such as the Manufacturer Submission of Average Sales Price (ASP) Data for Medicare Part B Drugs. The agency is inviting comments on the burden estimate and the utility of the information collection, and specific details including deadlines and instructions for submitting comments are provided.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Revision of the Bona Fide Service Fee Certification form
- Update on burden estimates
- Continuation of previous information collection notice
Obligations
What this law requires
Manufacturers must submit Average Sales Price (ASP) data for Medicare Part B drugs and biologicals to CMS on a quarterly basis
Manufacturers must submit Bona Fide Service Fee Certification form (CMS-10110) as part of ASP data submission
CMS must publish a 30-day notice in the Federal Register before submitting any information collection request to OMB for approval
CMS must obtain approval from the Office of Management and Budget (OMB) for each collection of information conducted or sponsored
Members of the public must submit comments on proposed information collections by the specified deadline (May 7, 2026 for this collection)